AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « pneumonia »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
pneumocytes < pneumonia < pneumonitis  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000011 (2020) Binqing Fu ; Xiaoling Xu ; Haiming WeiWhy tocilizumab could be an effective treatment for severe COVID-19?
000044 (2020) Ernest H. Choy [Royaume-Uni] ; Fabrizio De Benedetti [Italie] ; Tsutomu Takeuchi [Japon] ; Misato Hashizume [Japon] ; Markus R. John [Suisse] ; Tadamitsu Kishimoto [Japon]Translating IL-6 biology into effective treatments
000075 (2020) Anca D. Askanase [États-Unis] ; Leila Khalili [États-Unis] ; Jill P. Buyon [États-Unis]Thoughts on COVID-19 and autoimmune diseases
000079 (2020) Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000081 (2020) Francisco Vílchez-Oya [Espagne] ; Julia María Sánchez-Schmidt [Espagne] ; Anna Agustí [Espagne] ; Ana Pros [Espagne]The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review.
000097 (2020) Weiyi Tan ; Jamil AboulhosnThe cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
000099 (2020) Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie]The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
000150 (2020) Giovanna Garufi [Italie] ; Luisa Carbognin [Italie] ; Armando Orlandi [Italie] ; Giampaolo Tortora [Italie] ; Emilio Bria [Italie]Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence.
000187 (2020) Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan ; Olena Zimba [Ukraine]Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
000207 (2020) Shengyu Zhang ; Lei Li ; Aizong Shen ; Yongwu Chen ; Zhigang QiRational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
000209 (2020) Gonzalo De Luna [France] ; Anoosha Habibi [France] ; Jean François Deux [France] ; Martin Colard [France] ; Anne Laure Pham Hung D'Alexandry D'Orengiani [France] ; Frédéric Schlemmer [France] ; Nizar Joher [France] ; Christian Kassasseya [France] ; Jean Michel Pawlotsky [France] ; Clément Ourghanlian [France] ; Marc Michel [France] ; Armand Mekontso-Dessap [France] ; Pablo Bartolucci [France]Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab.
000214 (2020) Alyson W. Wong [Canada] ; Christopher J. Ryerson [Canada] ; Sabina A. Guler [Suisse]Progression of fibrosing interstitial lung disease
000245 (2020) Ana Luisa Oliveira [Portugal] ; Carina Ruano [Portugal] ; Nuno Riso [Portugal] ; José Cepeda Ribeiro [Portugal] ; Maria Francisca Moraes-Fontes [Portugal]Paradoxical pulmonary event under tocilizumab treatment for systemic sclerosis-associated usual interstitial pneumonia.
000384 (2020) M. Cellina [Italie] ; M. Orsi [Italie] ; F. Bombaci [Italie] ; M. Sala [Italie] ; P. Marino [Italie] ; G. Oliva [Italie]Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab.
000393 (2020) Dinesh Khanna ; Donald P. Tashkin ; Christopher P. Denton ; Elisabetta A. Renzoni ; Sujal R. Desai ; John VargaEtiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
000420 (2020) Chihiro Iwao [Japon] ; Kunihiko Umekita [Japon] ; Shunichi Miyauchi [Japon] ; Masatoshi Kimura [Japon] ; Yuki Rikitake [Japon] ; Koushou Iwao [Japon] ; Mao Rikitake [Japon] ; Ayako Aizawa [Japon] ; Takeshi Kawaguchi [Japon] ; Yumi Kariya [Japon] ; Motohiro Matsuda [Japon] ; Ichiro Takajo [Japon] ; Kazutaka Shiomi [Japon] ; Akihiko Okayama [Japon]Effective Treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell Leukemia Virus Type 1-associated Myelopathy: A Case Report.
000456 (2020) Francesco Fontana [Italie] ; Gaetano Alfano [Italie] ; Giacomo Mori [Italie] ; Alessio Amurri [Italie] ; Tei Lorenzo [Italie] ; Marco Ballestri [Italie] ; Marco Leonelli [Italie] ; Francesca Facchini [Italie] ; Francesca Damiano [Italie] ; Riccardo Magistroni [Italie] ; Gianni Cappelli [Italie]Covid-19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and Hydroxychloroquine.
000469 (2020) Jehun Song [Corée du Sud] ; Seongmin Kang [Corée du Sud] ; Seung Won Choi [Corée du Sud] ; Kwang Won Seo [Corée du Sud] ; Sunggun Lee [Corée du Sud] ; Min Wook So [Corée du Sud] ; Doo-Ho Lim [Corée du Sud]Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs
000531 (2020) Xuetao Cao [République populaire de Chine]COVID-19: immunopathology and its implications for therapy
000547 (2020) Jhuma Sankar ; Nitin Dhochak ; S. K. Kabra ; Rakesh LodhaCOVID-19 in Children: Clinical Approach and Management
000587 (2020) A. Ahmad [Arabie saoudite] ; M U Rehman ; K M AlkharfyAn alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "pneumonia" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "pneumonia" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    pneumonia
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021